Incyte to Report Fourth Quarter and Year-End Financial Results
Get Alerts INCY Hot Sheet
Join SI Premium – FREE
WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its fourth quarter and year end 2017 financial results conference call and webcast for 10:00 a.m. ET on Thursday, February 15, 2018.
The schedule for the press release and conference call/webcast is as follows:
• Q4 & YE 2017 Press Release: |
February 15, 2018 at 7:00 a.m. ET | ||||
• Q4 & YE 2017 Conference Call: |
February 15, 2018 at 10:00 a.m. ET | ||||
• Domestic Dial-In Number: |
877-407-3042 | ||||
• International Dial-In Number: |
201-389-0864 | ||||
• Conference ID Number: |
13675376 | ||||
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13675376.
The live webcast with slides can be accessed at www.incyte.com under For Investors, Events and Presentations and will be available for replay for 30 days.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's website at www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180124005007/en/
Incyte Corporation
Investors
Michael Booth, DPhil, +1
302-498-5914
[email protected]
or
Media
Catalina
Loveman, +1 302-498-6171
[email protected]
Source: Incyte Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte (INCY) PT Lowered to $84 at Oppenheimer
- Customers Bancorp (CUBI) Tops Q1 EPS by 3c
- Incyte (INCY) PT Lowered to $64 at BofA Securities
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Twitter, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!